摘要
自1973年1月至1992年12,本院共收治肝癌737例,手术切除190例,切除率为25.78％。术后肝内复发者104例占54.73％,其中1年内复发者占70.19％(70/104),2年内占20.19％(21/104),3年内占9.61％。复发后再探查19例,探查率18.26％,能切除者仅8例,占复发104例的7.69％。再切除术后平均生存28个月。其中2例积累生存分别为58和84个月。不能切除者,静脉化疗4例平均生存3.5个月,肝动脉插管化疗2例平均生存6.5月,经导管超选择插管碘油抗癌乳剂栓塞化疗14例,平均生存期13.9个月。以再切除效果最佳,介入治疗次之,肝动脉插管化疗和全身静脉化疗效果较差。
From Jan. 1973 to Dec. 1990,737 patients with hepatic carcinoma have been treated in our department. Resections were performed in 190 patients, the resection rate was 25.78%. The recurrences after the resections were detected in 104 cases, accounted to 54.73%. The recurrent rate within the 1st year was 70.91% (70/104), the 2nd year, 20.19% (21/104), The cumulative recurrent rate of the first two years was 90,.38% . the 3rd year, 9.61% . 19 recurrent cases have been operated for exploration again. Secondary resections could be Performed in 8 cases only, the secondary resection rate was 7.69% among the 104 recurrent cases. The average survival period after resections was 28 months, 2 cases of them survived for 58 and 58 months, respectively, Among the unresectable cases in the secondary exploration, 4 cases were treated by intravenous chemotherapy, with an average survival period of 3.8 months; 2 cases were treated by intrahepatic arterial infusion chemotherapy, with an average survival period of. 6.5 months; 14 cases were treated by the supraselective intrahepatic arterial infusion lipiodol chemoembolization, with an average survival period of 13.9 months. The therapeutic result of secondary resection is the best; chemoembolization the second; transcatheter hepatic arterial chemotherapy worse; intravenous chemotherapy, the worst.
出处
《癌症》
SCIE
CAS
CSCD
北大核心
1993年第5期437-439,共3页
Chinese Journal of Cancer
关键词
癌
切除术
肝肿瘤
复发
治疗
Liver cancer Resection Secondary recesction
